Comparative efficacy of vedolizumab and adalimumab in ulcerative colitis patients previously treated with infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - Inflammatory bowel …, 2019 - academic.oup.com
Background Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate to
severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative …
被引用次数：43 相关文章

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - INFLAMMATORY …, 2019 - iris.unime.it
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously
Treated With Infliximab IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.

A Favale, S Onali, F Caprioli, D Pugliese… - Inflammatory Bowel …, 2019 - europepmc.org
BACKGROUND: Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in
moderate to severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - Inflammatory Bowel …, 2019 - academic.oup.com
Background Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate to
severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.

A Favale, S Onali, F Caprioli, D Pugliese… - Inflammatory Bowel …, 2019 - go.gale.com
Background: Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate
to severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli… - Inflammatory …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate to
severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative …

[引用][C] Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - INFLAMMATORY …, 2019 - iris.hunimed.eu
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously
Treated With Infliximab IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.

A Favale, S Onali, F Caprioli, D Pugliese… - INFLAMMATORY …, 2019 - iris.unina.it
BACKGROUND: Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in
moderate to severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - INFLAMMATORY …, 2019 - art.torvergata.it
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously
Treated With Infliximab IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab

A Favale, S Onali, F Caprioli, D Pugliese… - INFLAMMATORY …, 2019 - iris.unica.it
Background: Adalimumab (ADA) and vedolizumab (VDZ) have shown efficacy in moderate
to severe ulcerative colitis (UC) patients who failed infliximab (IFX). Although, a comparative …